Treatment of Hospital-Acquired Infections in Patients with Cirrhosis – New Challenges

References

• Gomez F, Ruiz P, Schreiber AD. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med. 1994;331:1122–1128. doi:10.1056/NEJM199410273311704
   PubMed Web of Science ®Google Scholar
• Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9(9):727–738. doi:10.1016/j.cgh.2011.02.031
   PubMed Web of Science ®Google Scholar
• Fernández J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55(5):1551–1561. doi:10.1002/hep.25532
   PubMed Web of Science ®Google Scholar
• Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Digest Liver Dis. 2001;33:41–48. doi:10.1016/S1590-8658(01)80134-1
   Web of Science ®Google Scholar
• Moreau R, Jalan R, Gines P, et al. Acute-on- chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–1437. doi:10.1053/j.gastro.2013.02.042
   PubMed Web of Science ®Google Scholar
• Costabeber AM, de Mattos AA, Sukiennik TCT. Prevalence of bacterial resistance in hospitalized cirrhotic patients in southern Brazil: a new challenge. Rev Inst Med Trop Sao Paulo. 2016;58(1):1–7. doi:10.1590/S1678-9946201658036
   Web of Science ®Google Scholar
• Alexopoulou A, Vasilieva L, Agiasotelli D. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia. World J Gastroenterol. 2016;22(15):4049–4056. doi:10.3748/wjg.v22.i15.4049
   PubMed Web of Science ®Google Scholar
• Inweregbu K, Dave J, Pittard A. Nosocomial infections. Contin Educ Anaesthes Crit Care Pain. 2005;5(1):14–17. doi:10.1093/bjaceaccp/mki006
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Miranda-Zazueta G, Ponce de León-garduño LA, Aguirre-Valadez J, et al. Bacterial infections in cirrhosis: current treatment. Ann Hepatol. 2020;19(3):238–244. doi:10.1016/j.aohep.2019.09.011
   Web of Science ®Google Scholar
• Aparicio JR, Such J, Pascual S, et al. Development of Quinolone –resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. J Hepatol. 1999;31:277–283. doi:10.1016/s0168-8278(99)80225-6
   PubMed Web of Science ®Google Scholar
• Cereto F, Herranz X, Moreno E, et al. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol. 2008;20:924–929. doi:10.1097/MEG.0b013e3282fc7390
   Web of Science ®Google Scholar
• Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35(1):140–148. doi:10.1053/jhep.2002.30082
   PubMed Web of Science ®Google Scholar
• De Conto Oliveira J, Carrera E, Petry R, et al. High prevalence of multidrug resistant bacteria in cirrhotic patients with spontaneous bacterial peritonitis: is it time to change the standard antimicrobial approach? Can J Gastroenterol Hepatol. 2019;6963910:1–6.
   Web of Science ®Google Scholar
• Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013. J Hepatol. 2014;60:1310‐1324. doi:10.1016/j.jhep.2014.01.024
   Web of Science ®Google Scholar
• Fernández J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol. 2012;56:S1‐S12. doi:10.1016/S0168-8278(12)60002-6
   Web of Science ®Google Scholar
• Arabi YM, Dara SI, Memish Z, et al. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatol. 2012;56:2305‐2315. doi:10.1002/hep.25931
   Web of Science ®Google Scholar
• Merli M, Lucidi C, Di Gregorio V, et al. An empirical broad spectrum antibiotic therapy in health-care associated infections improves survival in patients with cirrhosis: a randomized trial. Hepatol. 2016;63:1632‐1639. doi:10.1002/hep.28332
   Web of Science ®Google Scholar
• Piano S, Fasolato S, Salinas F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatol. 2016;63:1299‐1309. doi:10.1002/hep.27941
   Web of Science ®Google Scholar
• Fernandez J, Arroyo V. Bacterial infections in cirrhosis: a growing problem with significant implications. Clin Liver Dis. 2013;2(3):102–105. doi:10.1002/cld.169
   Google Scholar
• Tasina E, Haidich AB, Kokkali S, et al. Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. Lancet Infect Dis. 2011;11(11):834–844. doi:10.1016/S1473-3099(11)70177-3
   PubMed Web of Science ®Google Scholar
• Shen F, Han Q, Xie D, et al. Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs. Int J Infect Dis. 2015;39:25–33. doi:10.1016/j.ijid.2015.08.009
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Reddy KR, Tandon P, et al. Prediction of fungal infection development and their impact on survival using the NACSELD cohort. Am J Gastroenterol. 2018;113:556–563. doi:10.1038/ajg.2017.471
   Web of Science ®Google Scholar
• Piano S, Angeli P. Current concepts on bacterial and fungal infections in cirrhosis. Clin Liver Dis. 2019;14(3):87–91. doi:10.1002/cld.799
   Google Scholar
• O’Leary JG, Reddy KR, Wong F, et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13:753–759. doi:10.1016/j.cgh.2014.07.060
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Vargas HE, Reddy KR, et al. Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis. Clin Gastroenterol Hepatol. 2019;17:756–765. doi:10.1016/j.cgh.2018.07.022
   Web of Science ®Google Scholar
• Claria J, Stauber RE, Coenraad MJ, et al. Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatol. 2016;64:1249–1264. doi:10.1002/hep.28740
   PubMed Web of Science ®Google Scholar